 |
 |

When Should Perioperative -Blockers Be Discontinued?
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their review of perioperative -blockade for noncardiac surgery, Drs Auerbach and Goldman1 may have created some confusion about the potential for complications of withdrawal of -blockade. They summarize an article by Shammash et al2 as follows: "A recent prospective observational study noted that patients who were not receiving -blockers long-term but who discontinued perioperative use immediately after surgery had an increased risk for postoperative myocardial infarction."
In fact, this article reports a retrospective review of medical records of patients who received -blockers before surgery. Patients whose -blockade was continued into the postoperative period were compared with patients whose -blockade was not reinstituted. Most of the regimens described to date for perioperative -blockade extend significantly into the postoperative period.3-4 Although there is the potential for a rebound reaction following the institution of perioperative -blockade, the literature reviewed does not address that situation. In particular, it remains unclear . . . [Full Text of this Article]
RELATED ARTICLE
-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review
Andrew D. Auerbach and Lee Goldman
JAMA. 2002;287(11):1435-1444.
ABSTRACT
| FULL TEXT
|